Immuron Ltd — AGM Information 2014

Nov 12, 2014

IMMURON AGM Nov 2014

==> picture [721 x 271] intentionally omitted <==

2

==> picture [721 x 271] intentionally omitted <==

----- Start of picture text -----

Forward-looking Statement
Certain statements made in this presentation are forward-looking
statements and are based on Immuron’s current expectations, estimates
and projections. Words such as “anticipates,” “expects,” “intends,” “plans,”
“believes,” “seeks,” “estimates,” “guidance” and similar expressions are
intended to identify forward-looking statements.
Although Immuron believes the forward-looking statements are based on
reasonable assumptions, they are subject to certain risks and uncertainties,
----- End of picture text -----

NASH/ASH

==> picture [87 x 25] intentionally omitted <==

----- Start of picture text -----

TRAVELAN®
----- End of picture text -----

==> picture [101 x 25] intentionally omitted <==

----- Start of picture text -----

LOOKING FORWARD
----- End of picture text -----

==> picture [87 x 24] intentionally omitted <==

----- Start of picture text -----

PIPELINE
----- End of picture text -----

NASH: Travelan:

Trials are “go ready” An increasingly alluring potential upside

Revenues growing and positioned to grow further

Pipeline: Progressing Cap Str: Robust Financials:

Debt free, cash in the bank until after completion of NASH trial

3

TRAVELAN®

NASH/ASH PIPELINE

==> picture [101 x 23] intentionally omitted <==

----- Start of picture text -----

LOOKING FORWARD
----- End of picture text -----

4

==> picture [452 x 25] intentionally omitted <==

----- Start of picture text -----

Overview,
TRAVELAN® NASH/ASH PIPELINE LOOKING FORWARD
Achievements
----- End of picture text -----

	Nov 2013	Nov/Dec 2014
Cash Debt Share Register Improved Partner Royalties	• <$1M cash at 30 Dec 13 • CAD1.5M Paladin Debt owing • 1,800 shareholders on register • Share register dispersed • 3B shares on issue • Hadasit royalty rates	5 Immuron AGM Presentation �$6M cash at 30 June 14 �Debt Free �~1,200 SH following Mop Up �Top 20 own >50% �~75M shares on issue �Improved Pending shareholder approval

2.

==> picture [721 x 271] intentionally omitted <==

----- Start of picture text -----

TRAVELAN
ACHIEVEMENTS
----- End of picture text -----

Overview, Achievements

==> picture [172 x 25] intentionally omitted <==

----- Start of picture text -----

NASH PIPELINE
----- End of picture text -----

==> picture [98 x 25] intentionally omitted <==

----- Start of picture text -----

LOOKING FORWARD
----- End of picture text -----

Increasing Australian Presence

==> picture [203 x 136] intentionally omitted <==

7

Overview, Achievements

==> picture [172 x 25] intentionally omitted <==

----- Start of picture text -----

NASH PIPELINE
----- End of picture text -----

==> picture [98 x 25] intentionally omitted <==

----- Start of picture text -----

LOOKING FORWARD
----- End of picture text -----

==> picture [203 x 136] intentionally omitted <==

8

==> picture [87 x 25] intentionally omitted <==

----- Start of picture text -----

Overview,
Achievements
----- End of picture text -----

NASH PIPELINE

LOOKING FORWARD

==> picture [203 x 136] intentionally omitted <==

9

==> picture [87 x 25] intentionally omitted <==

----- Start of picture text -----

Overview,
Achievements
----- End of picture text -----

==> picture [277 x 26] intentionally omitted <==

----- Start of picture text -----

NASH PIPELINE LOOKING FORWARD
----- End of picture text -----

==> picture [203 x 136] intentionally omitted <==

10

==> picture [87 x 25] intentionally omitted <==

----- Start of picture text -----

Overview,
Achievements
----- End of picture text -----

NASH PIPELINE

==> picture [105 x 25] intentionally omitted <==

----- Start of picture text -----

LOOKING FORWARD
----- End of picture text -----

==> picture [589 x 167] intentionally omitted <==

11

==> picture [87 x 25] intentionally omitted <==

----- Start of picture text -----

Overview,
Achievements
----- End of picture text -----

==> picture [172 x 25] intentionally omitted <==

----- Start of picture text -----

NASH PIPELINE
----- End of picture text -----

==> picture [105 x 24] intentionally omitted <==

----- Start of picture text -----

LOOKING FORWARD
----- End of picture text -----

Status in Nov 2013

Progress in 2014

Country Discussions Term Sheet Licensed Regulatory In Market

Canada South Korea Other Asian Countries US (partnered)

No regulatory process

United States (direct) India China

• Regulatory application preceding partnering engagement

12

3.

==> picture [721 x 271] intentionally omitted <==

----- Start of picture text -----

NASH/ASH
(INFLAMED
FATTY LIVER)
----- End of picture text -----

==> picture [87 x 25] intentionally omitted <==

----- Start of picture text -----

Overview,
Achievements
----- End of picture text -----

==> picture [175 x 25] intentionally omitted <==

----- Start of picture text -----

TRAVELAN NASH/ASHNASH/ASHNASH/ASH
----- End of picture text -----

==> picture [173 x 25] intentionally omitted <==

----- Start of picture text -----

NASH/ASHNASH/ASHNASH/ASH PIPELINE
----- End of picture text -----

==> picture [105 x 25] intentionally omitted <==

----- Start of picture text -----

LOOKING FORWARD
----- End of picture text -----

February 2014

Update 1. Protocol 2. Investigational Brochure

Formulation and manufacture of clinical trial material

November 2014 Ready to start

Hospitals

14

==> picture [454 x 25] intentionally omitted <==

----- Start of picture text -----

Overview,
Achievements TRAVELAN NASH/ASH PIPELINE LOOKING FORWARD
----- End of picture text -----

MRI VirtualScopics Medical Monitor Rochester NY Prof Y Ilan Hadassah Medical Center Israel Liver biopsy/M’biome Duke CRI Central Pharmacy US Durham NC The Coghlan Group DM & Stats Bastrop, TX Datapharm Aust. Sydney, Australia Packing & Central Pharmacy AUS Pharmaceutical Packaging Prof.

Biomarker specimens

15

Sites - Australia

==> picture [211 x 299] intentionally omitted <==

Princess Alexandra Hospital, Brisbane, QLD

==> picture [71 x 57] intentionally omitted <==

Nepean Hospital, Sydney, NSW Box Hill Hospital Melbourne, VIC

==> picture [724 x 541] intentionally omitted <==

----- Start of picture text -----

Sites – United States
Swedish MC Seattle, WA
UVA, Charlottesville VA
VCU, Richmond VA
Bon Secours, Richmond/NN
Cleveland Clinic, OH
U.Colorado, Denver, CO
Duke Liver Center,
Kansas City GE&H, MO
Durham NC
U Florida, Gainesville, FL
Baylor St Luke’s
Houston, TX 17
Immuron
Investor
Presentation
Nov 2014
----- End of picture text -----

4.

==> picture [721 x 271] intentionally omitted <==

----- Start of picture text -----

PIPELINE
----- End of picture text -----

Overview, Achievements

==> picture [87 x 25] intentionally omitted <==

----- Start of picture text -----

TRAVELAN®
----- End of picture text -----

==> picture [175 x 26] intentionally omitted <==

----- Start of picture text -----

NASH/ASH PIPELINE
----- End of picture text -----

==> picture [189 x 25] intentionally omitted <==

----- Start of picture text -----

PIPELINE LOOKING FORWARD
----- End of picture text -----

19

5.

==> picture [721 x 271] intentionally omitted <==

----- Start of picture text -----

LOOKING
FORWARD
----- End of picture text -----

NASH/ASH PIPELINE

Overview, TRAVELAN® Achievements

21

==> picture [721 x 271] intentionally omitted <==

----- Start of picture text -----

THANK YOU
----- End of picture text -----

Chief Executive Officer Amos Meltzer amos@immuron.com